National Policy for containment of antimicrobial resistance
Antimicrobial resistance in pathogens causing important communicable diseases has become a matter of great public health concern globally including our country. Resistance has emerged even to newer, more potent antimicrobial agents like carbapenems. The factors responsible for this are widespread use and availability of practically all the antimicrobials across the counter meant for human, animal and industrial consumption. There are definite policies / guidelines for appropriate use of antimicrobials at national level in specific national health programmes being run in the country e.g. RNTCP, National AIDS control programme, etc. For other diseases of public health importance like enteric fever, diarrhoeal disease, respiratory infections, etc the individual hospitals are following their own antimicrobial policies and hospital infection control guidelines. To monitor antimicrobial resistance it is necessary to have regulations for use and misuse of antibiotics in the country, creation of national surveillance system for antibiotic resistance, mechanism of monitoring prescription audits, regulatory provision for monitoring use of antibiotics in human, veterinary & industrial sectors and identification of specific intervention measures for rational use of antibiotics. (Developed under the Chairpersonship of Dr. R. K. Srivastava).
Related Content
- Bracing for superbugs: strengthening environmental action in the one health response to antimicrobial resistance
- Bacterial vaccines in clinical and preclinical development 2021: an overview and analysis
- Monitoring global progress on addressing antimicrobial resistance: analysis report of the second round of results of AMR country self-assessment survey 2018
- Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
- Govt to put antibiotic use in poultry, fish under scanner